tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Regulatory Momentum and Expanding Clinical Footprint Position Insight Molecular Diagnostics for a Pivotal 2026 Ramp
PremiumRatingsRegulatory Momentum and Expanding Clinical Footprint Position Insight Molecular Diagnostics for a Pivotal 2026 Ramp
1M ago
iMDx prepares for U.S. commercial launch of GraftAssureDx
Premium
The Fly
iMDx prepares for U.S. commercial launch of GraftAssureDx
1M ago
Fourteen new option listings on November 12th
Premium
The Fly
Fourteen new option listings on November 12th
3M ago
Insight Molecular Diagnostics Advances Kidney Transplant Monitoring with New Study
PremiumCompany AnnouncementsInsight Molecular Diagnostics Advances Kidney Transplant Monitoring with New Study
4M ago
Insight Molecular says kidney transplant patient achieved ‘immune reset’
Premium
The Fly
Insight Molecular says kidney transplant patient achieved ‘immune reset’
4M ago
Insight Molecular Diagnostics Extends Executive Employment Agreement
Premium
Company Announcements
Insight Molecular Diagnostics Extends Executive Employment Agreement
5M ago
OncoCyte Corp’s Earnings Call: Progress Amid Challenges
PremiumCompany AnnouncementsOncoCyte Corp’s Earnings Call: Progress Amid Challenges
6M ago
Hold Rating for Insight Molecular Diagnostics Amid Strategic Expansion and Market Challenges
Premium
Ratings
Hold Rating for Insight Molecular Diagnostics Amid Strategic Expansion and Market Challenges
6M ago
IMDX’s GraftAssureDx Study: A Game-Changer in Kidney Transplant Monitoring?
Premium
Company Announcements
IMDX’s GraftAssureDx Study: A Game-Changer in Kidney Transplant Monitoring?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100